Home   Chapter Home   Jobs   Conferences   Fellowships   Books



Advertisement


Advertisement

General
=========================================================================

Case reports
=========================================================================

Treatment
=========================================================================

Gross description
=========================================================================

Micro description
=========================================================================

Micro images
=========================================================================

Extensive necrosis

Pleomorphic tumor cells with necrosis

Tumor cells invade vessel walls without fibrinoid necrosis

Keratin negative, with positive internal control

CD20 negative


CD3+

CD56+

EBV+ (by ISH)

TIA+


Various images


Prior to radiotherapy

Post-radiotherapy cardiac involvement

Positive stains
=========================================================================

Negative stains
=========================================================================

Molecular description
=========================================================================

Molecular images
=========================================================================

Monoclonal proliferation of EBV+ cells

Differential diagnosis
=========================================================================

End of Nasal cavity > Hematologic conditions > NK / T cell lymphoma, nasal type



Advertisement


This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).